Page last updated: 2024-12-08

benanomicin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

benanomicin A: from Actinomycete sp. MH193-16F4; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5464367
SCHEMBL ID15531435
MeSH IDM0159228

Synonyms (10)

Synonym
d-alanine, n-((5-((6-deoxy-3-o-beta-d-xylopyranosyl-beta-d-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5s-trans)-
(2r)-2-[[(5s,6s)-5-[(2s,3r,4s,5s,6r)-3,5-dihydroxy-6-methyl-4-[(2s,3r,4s,5r)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic aci
d-alanine, n-((5-((6-deoxy-3-o-.beta.-d-xylopyranosyl-.beta.-d-galactopyranosyl)-oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5s-trans)-
116249-65-1
benanomicin a
(2r)-2-[[(5s,6s)-5-[(2s,3r,4s,5s,6r)-3,5-dihydroxy-6-methyl-4-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid
SCHEMBL15531435
GOYUMGXIFMGKFN-NUVDETJMSA-N
DTXSID801317567
AKOS040756021

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Each dosage group consisted of 10 mice."( Successful treatment of Pneumocystis carinii Pneumonia in mice with benanomicin A (ME1451).
Kitada, K; Komuro, K; Kondo, S; Nakamura, Y; Oka, S; Shibahara, S; Shimada, K; Shimizu, H; Takeuchi, T; Yasuoka, A, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (18.18)18.7374
1990's14 (63.64)18.2507
2000's3 (13.64)29.6817
2010's1 (4.55)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]